GDF15 Weight Loss Effects Vary by Diet and Age in Mice, Complicating Therapeutics

A new study examining GDF15, a stress-responsive hormone being developed for obesity treatment, reveals its effects on metabolism are surprisingly context-dependent based on both diet composition and age. GDF15 has gained attention as a potential anti-obesity therapeutic because it reduces appetite and body weight, but this research shows its metabolic impacts vary significantly across different tissues depending on what animals eat and how old they are. This complexity matters for longevity science because GDF15 is also elevated during caloric restriction and certain longevity interventions, raising questions about whether it's a beneficial adaptive signal or a marker of metabolic stress. The tissue-specific, context-dependent effects suggest that simply increasing GDF15 levels therapeutically might not replicate the benefits seen in natural longevity interventions. The age-dependency is particularly important—effects seen in young animals may not translate to older individuals, the primary target population for metabolic interventions. These findings underscore the challenge of translating biomarker-guided therapies into practice and suggest GDF15-based treatments will require careful consideration of patient diet, age, and metabolic context.